Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
 
Register | Sign in
Home Page>Products
  Product News
EKF Diagnostics’ Growing Product Portfolio Highlighted at AACC 2014
Thursday, July 24, 2014
From early detection of ketosis to cancer mutation testing in whole blood.

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology
Thursday, July 24, 2014
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

R&D 100 Award 2014 for ZEISS ELYRA P.1 with 3D-PALM
Thursday, July 24, 2014
ZEISS is receiving Research & Development award once more.

Seward Introduces New Stomacher® Bag Options at IAFP 2014
Thursday, July 24, 2014
See Seward’s gold standard food microbiology range of blenders and accessories on Booth #643, Indiana Convention Center, Indianapolis, 3rd to 6th August 2014.

WHEATON® Highlights Products at AACC 2014
Thursday, July 24, 2014
The products to be featured at the meeting offer unique solutions for the clinical market.

Bioo Scientific Launches 16S V1 – V3 rRNA Library Prep Kits for Bacterial Metagenomics Studies
Wednesday, July 23, 2014
This kit allows users to go from sample to sequence in two hours, making it the fastest library prep kit available.

New Data Using EKF PointMan™ Technology
Tuesday, July 22, 2014
New data suggest the possibility of a simple blood test for cancers.

Asylum Research Opens an AFM Demonstration Lab in Mumbai, India
Tuesday, July 22, 2014
New lab to help researchers choose the best AFM for their research.

ChIP Sequencing Kit for Next Generation Sequencing
Tuesday, July 22, 2014
Company extends the benefits of their Chromatrap® solid state ChIP technology.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 10432
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv